May 6, 2014 — The National Lipid Association (NLA) recently convened an expert panel to examine various aspects of ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
April 29, 2014 — Armetheon Inc. announced it has reached agreement with the U.S. Food and Drug Administration (FDA) on a ...
April 21, 2014 — Decision Resources Group announced in a report that Servier's ivabradine (procoralan) is set to become ...
April 10, 2014 — The 2014 Guideline for the Management of Patients With Atrial Fibrillation includes recommendations for ...
April 9, 2014 — LipoScience Inc. announced data showing that patients managed to a target LDL particle (LDL-P) number ...
April 7, 2014 — In a comparison of two blood-thinning medications, heparin was associated with significantly fewer major ...
April 7, 2014 — Strategies aimed at reducing the number of patients with heart failure and other cardiovascular ...
April 2, 2014 — Statins are associated with a significant improvement in erectile function, a fact researchers hope will ...
March 25, 2014 – As long as inexpensive statins, which lower cholesterol, are readily available and patients do not mind ...
March 18, 2014 — Patients with coronary artery disease who received an Endeavor or Resolute drug-eluting stent from ...
March 12, 2014 — Janssen Research and Development LLC (Janssen) announced the U.S. Food and Drug Administration (FDA) ...
February 27, 2014 — Approximately one in two patients with atrial fibrillation (Afib) do not optimally reduce their risk ...
May 06, 2014